carbachol has been researched along with Hypertension, Pulmonary in 7 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the pulmonary artery isolated from 1-week hypoxia-induced pulmonary hypertensive rats, endothelial NO production stimulated by carbachol was decreased significantly in in situ visualization using diaminofluorescein-2 diacetate and also in cGMP content." | 3.71 | Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. ( Hori, M; Karaki, H; Murata, T; Ozaki, H; Sato, K, 2002) |
| "Right ventricular hypertrophy was increased by 51%, 93% and 55%, respectively, at 14 days." | 1.31 | Differences in time-related cardiopulmonary responses to hypoxia in three rat strains. ( Bochnowicz, S; Hart, T; Hay, DW; Louden, C; Luttmann, MA; Osborn, RR; Underwood, DC, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurney, AM | 1 |
| Howarth, FC | 1 |
| Murata, T | 1 |
| Sato, K | 1 |
| Hori, M | 2 |
| Ozaki, H | 2 |
| Karaki, H | 2 |
| Matsukura, Y | 1 |
| Washizu, M | 1 |
| Kondo, M | 1 |
| Motoyoshi, S | 1 |
| Itoh, A | 1 |
| Nakajyo, S | 1 |
| Shimizu, K | 1 |
| Urakawa, N | 1 |
| Nakazawa, H | 1 |
| Bochnowicz, S | 1 |
| Osborn, RR | 1 |
| Luttmann, MA | 1 |
| Louden, C | 1 |
| Hart, T | 1 |
| Hay, DW | 1 |
| Underwood, DC | 1 |
| Karamsetty, MR | 1 |
| Klinger, JR | 1 |
| Hill, NS | 1 |
| Both, A | 1 |
7 other studies available for carbachol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries.
Topics: Animals; Calcium Signaling; Carbachol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dinop | 2009 |
Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension.
Topics: Animals; Blotting, Western; Body Weight; Calcium; Carbachol; Cell Membrane; Cyclic GMP; Electrophore | 2002 |
Decreased pulmonary arterial endothelium-dependent relaxation in heartworm-infected dogs with pulmonary hypertension.
Topics: Animals; Blood Pressure; Carbachol; Dirofilariasis; Dog Diseases; Dogs; Endothelium, Vascular; Femal | 1997 |
Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Body Weight; Calcium; Carbachol; Cyclic GMP; Endothelium, Vascular; Hypertension, Pulmonary | 1999 |
Differences in time-related cardiopulmonary responses to hypoxia in three rat strains.
Topics: Altitude; Animals; Carbachol; Disease Models, Animal; Endothelin-1; Endothelins; Hypertension, Pulmo | 2000 |
Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
Topics: Animals; Carbachol; Cholinergic Agonists; Chronic Disease; Dose-Response Relationship, Drug; Estradi | 2001 |
[Therapy of primary pulmonary hypertension].
Topics: Acetylcholine; Amino Alcohols; Carbachol; Child; Diazepam; Diazoxide; Female; Humans; Hypertension, | 1970 |